Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
Gespeichert in:
| Veröffentlicht in: | The Journal of infection 2021-01, Vol.82 (1), p.e22-e24 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e24 |
|---|---|
| container_issue | 1 |
| container_start_page | e22 |
| container_title | The Journal of infection |
| container_volume | 82 |
| creator | Kevorkian, Jean-Philippe Riveline, Jean-Pierre Vandiedonck, Claire Girard, Diane Galland, Joris Féron, Florine Gautier, Jean-François Mégarbane, Bruno |
| description | |
| doi_str_mv | 10.1016/j.jinf.2020.08.045 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7462464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016344532030579X</els_id><sourcerecordid>2440472536</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-232b96770af94c70bb23f4b9573f01328fe28576931cd0c902d2c9c2345c23633</originalsourceid><addsrcrecordid>eNp9kc1u1DAUhS0EotOBF2CBvIRFgv-S2AhVGg2FVhqpG9qt5TgO41FiD7Yz0rwCT43TKVXLgo1t2ed8914fAN5hVGKE60-7cmddXxJEUIl4iVj1AixwRUlBGkZegkUW0YKxip6B8xh3CCFBRf0anFHCORdNvQC_L1UYjjBufUiF9lOIBup8ttrHZIK3XYTKdbCfgo9mtN38PLbWqWS9g8nDFIxK0HlX6GCzTw2ZZ4cBrm_urr8WWMB91hqX4me4ctC30YTDvVsNmTUXhjFN3fENeNWrIZq3D_sS3H67_LG-KjY336_Xq02hGRepIJS0om4apHrBdIPaltCetaJqaI9wnqw3hFdNLSjWHdICkY5ooQllVV5qSpfg4sTdT-1oOp1bC2qQ-2BHFY7SKyufvzi7lT_9QTasJqxmGfDxBNj-Y7tabeR8hyiveFXjA87aDw_Fgv81mZjkaKM2w6Cc8VOUhDHEGlLlxpaAnKQ6f3UMpn9kYyTnwOVOzoHLOXCJuMyBZ9P7p8M8Wv4mnAVfTgKTv_RgTZBR5zS06WwwOsnO2__x_wCKgb6J</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440472536</pqid></control><display><type>article</type><title>Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kevorkian, Jean-Philippe ; Riveline, Jean-Pierre ; Vandiedonck, Claire ; Girard, Diane ; Galland, Joris ; Féron, Florine ; Gautier, Jean-François ; Mégarbane, Bruno</creator><creatorcontrib>Kevorkian, Jean-Philippe ; Riveline, Jean-Pierre ; Vandiedonck, Claire ; Girard, Diane ; Galland, Joris ; Féron, Florine ; Gautier, Jean-François ; Mégarbane, Bruno</creatorcontrib><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2020.08.045</identifier><identifier>PMID: 32888976</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents - therapeutic use ; Cardiology and cardiovascular system ; Cohort Studies ; Comorbidity ; COVID-19 Drug Treatment ; Critical Illness - therapy ; Dexamethasone - therapeutic use ; Drug Therapy, Combination ; Emerging diseases ; Female ; Furosemide - therapeutic use ; Human health and pathology ; Humans ; Infectious diseases ; Letters to the Editor ; Life Sciences ; Male ; Methylprednisolone - therapeutic use ; Middle Aged ; Pulmonology and respiratory tract ; Respiratory Distress Syndrome - drug therapy ; Respiratory Distress Syndrome - prevention & control ; Retrospective Studies ; SARS-CoV-2 - drug effects ; Sodium Potassium Chloride Symporter Inhibitors - therapeutic use ; Toxicology</subject><ispartof>The Journal of infection, 2021-01, Vol.82 (1), p.e22-e24</ispartof><rights>2020 The British Infection Association</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved. 2020 The British Infection Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-232b96770af94c70bb23f4b9573f01328fe28576931cd0c902d2c9c2345c23633</citedby><cites>FETCH-LOGICAL-c489t-232b96770af94c70bb23f4b9573f01328fe28576931cd0c902d2c9c2345c23633</cites><orcidid>0000-0002-2522-2764</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jinf.2020.08.045$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32888976$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03858561$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kevorkian, Jean-Philippe</creatorcontrib><creatorcontrib>Riveline, Jean-Pierre</creatorcontrib><creatorcontrib>Vandiedonck, Claire</creatorcontrib><creatorcontrib>Girard, Diane</creatorcontrib><creatorcontrib>Galland, Joris</creatorcontrib><creatorcontrib>Féron, Florine</creatorcontrib><creatorcontrib>Gautier, Jean-François</creatorcontrib><creatorcontrib>Mégarbane, Bruno</creatorcontrib><title>Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Cardiology and cardiovascular system</subject><subject>Cohort Studies</subject><subject>Comorbidity</subject><subject>COVID-19 Drug Treatment</subject><subject>Critical Illness - therapy</subject><subject>Dexamethasone - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Emerging diseases</subject><subject>Female</subject><subject>Furosemide - therapeutic use</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Letters to the Editor</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Middle Aged</subject><subject>Pulmonology and respiratory tract</subject><subject>Respiratory Distress Syndrome - drug therapy</subject><subject>Respiratory Distress Syndrome - prevention & control</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2 - drug effects</subject><subject>Sodium Potassium Chloride Symporter Inhibitors - therapeutic use</subject><subject>Toxicology</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1u1DAUhS0EotOBF2CBvIRFgv-S2AhVGg2FVhqpG9qt5TgO41FiD7Yz0rwCT43TKVXLgo1t2ed8914fAN5hVGKE60-7cmddXxJEUIl4iVj1AixwRUlBGkZegkUW0YKxip6B8xh3CCFBRf0anFHCORdNvQC_L1UYjjBufUiF9lOIBup8ttrHZIK3XYTKdbCfgo9mtN38PLbWqWS9g8nDFIxK0HlX6GCzTw2ZZ4cBrm_urr8WWMB91hqX4me4ctC30YTDvVsNmTUXhjFN3fENeNWrIZq3D_sS3H67_LG-KjY336_Xq02hGRepIJS0om4apHrBdIPaltCetaJqaI9wnqw3hFdNLSjWHdICkY5ooQllVV5qSpfg4sTdT-1oOp1bC2qQ-2BHFY7SKyufvzi7lT_9QTasJqxmGfDxBNj-Y7tabeR8hyiveFXjA87aDw_Fgv81mZjkaKM2w6Cc8VOUhDHEGlLlxpaAnKQ6f3UMpn9kYyTnwOVOzoHLOXCJuMyBZ9P7p8M8Wv4mnAVfTgKTv_RgTZBR5zS06WwwOsnO2__x_wCKgb6J</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Kevorkian, Jean-Philippe</creator><creator>Riveline, Jean-Pierre</creator><creator>Vandiedonck, Claire</creator><creator>Girard, Diane</creator><creator>Galland, Joris</creator><creator>Féron, Florine</creator><creator>Gautier, Jean-François</creator><creator>Mégarbane, Bruno</creator><general>Elsevier Ltd</general><general>WB Saunders</general><general>The British Infection Association. Published by Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2522-2764</orcidid></search><sort><creationdate>20210101</creationdate><title>Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study</title><author>Kevorkian, Jean-Philippe ; Riveline, Jean-Pierre ; Vandiedonck, Claire ; Girard, Diane ; Galland, Joris ; Féron, Florine ; Gautier, Jean-François ; Mégarbane, Bruno</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-232b96770af94c70bb23f4b9573f01328fe28576931cd0c902d2c9c2345c23633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Cardiology and cardiovascular system</topic><topic>Cohort Studies</topic><topic>Comorbidity</topic><topic>COVID-19 Drug Treatment</topic><topic>Critical Illness - therapy</topic><topic>Dexamethasone - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Emerging diseases</topic><topic>Female</topic><topic>Furosemide - therapeutic use</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Letters to the Editor</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Middle Aged</topic><topic>Pulmonology and respiratory tract</topic><topic>Respiratory Distress Syndrome - drug therapy</topic><topic>Respiratory Distress Syndrome - prevention & control</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2 - drug effects</topic><topic>Sodium Potassium Chloride Symporter Inhibitors - therapeutic use</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kevorkian, Jean-Philippe</creatorcontrib><creatorcontrib>Riveline, Jean-Pierre</creatorcontrib><creatorcontrib>Vandiedonck, Claire</creatorcontrib><creatorcontrib>Girard, Diane</creatorcontrib><creatorcontrib>Galland, Joris</creatorcontrib><creatorcontrib>Féron, Florine</creatorcontrib><creatorcontrib>Gautier, Jean-François</creatorcontrib><creatorcontrib>Mégarbane, Bruno</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kevorkian, Jean-Philippe</au><au>Riveline, Jean-Pierre</au><au>Vandiedonck, Claire</au><au>Girard, Diane</au><au>Galland, Joris</au><au>Féron, Florine</au><au>Gautier, Jean-François</au><au>Mégarbane, Bruno</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>82</volume><issue>1</issue><spage>e22</spage><epage>e24</epage><pages>e22-e24</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32888976</pmid><doi>10.1016/j.jinf.2020.08.045</doi><orcidid>https://orcid.org/0000-0002-2522-2764</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0163-4453 |
| ispartof | The Journal of infection, 2021-01, Vol.82 (1), p.e22-e24 |
| issn | 0163-4453 1532-2742 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7462464 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adrenal Cortex Hormones - therapeutic use Aged Aged, 80 and over Anti-Inflammatory Agents - therapeutic use Cardiology and cardiovascular system Cohort Studies Comorbidity COVID-19 Drug Treatment Critical Illness - therapy Dexamethasone - therapeutic use Drug Therapy, Combination Emerging diseases Female Furosemide - therapeutic use Human health and pathology Humans Infectious diseases Letters to the Editor Life Sciences Male Methylprednisolone - therapeutic use Middle Aged Pulmonology and respiratory tract Respiratory Distress Syndrome - drug therapy Respiratory Distress Syndrome - prevention & control Retrospective Studies SARS-CoV-2 - drug effects Sodium Potassium Chloride Symporter Inhibitors - therapeutic use Toxicology |
| title | Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A43%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20short-course%20corticosteroids%20and%20furosemide%20combination%20to%20treat%20non-critically%20ill%20COVID-19%20patients:%20An%20observational%20cohort%20study&rft.jtitle=The%20Journal%20of%20infection&rft.au=Kevorkian,%20Jean-Philippe&rft.date=2021-01-01&rft.volume=82&rft.issue=1&rft.spage=e22&rft.epage=e24&rft.pages=e22-e24&rft.issn=0163-4453&rft.eissn=1532-2742&rft_id=info:doi/10.1016/j.jinf.2020.08.045&rft_dat=%3Cproquest_pubme%3E2440472536%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440472536&rft_id=info:pmid/32888976&rft_els_id=S016344532030579X&rfr_iscdi=true |